Skip to content

    Recently Viewed

      Listening...

      Learn about Johnson & Johnson’s strength in healthcare innovation

      We’re building a world where complex diseases are prevented and cured, treatments are smarter and less invasive—and solutions are personal.
      A video still of a black women smiling at the camera
      JJ_Launch_60_H264_16x9_Captioned_Adaptive Low Bitrate.mp4

      Innovative Medicine

      Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.

      MedTech

      Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.

      Solving the toughest health challenges

      Innovation
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Innovation
      Scientist examining a sample in a petri dish

      Could we be on our way to eliminating cancer for good?

      What once seemed like an out-of-reach goal may soon be within our grasp. Take an in-depth look at how Johnson & Johnson is working toward its vision of helping create a world without cancer.

      5 things we now know about atrial fibrillation

      More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2050, the number of cases will increase by 60%. For American Heart Month, learn the facts behind this heart condition, plus one patient’s diagnosis story.
      Innovation
      scientist-looking-through-microscope

      How Johnson & Johnson is advancing new options for bladder cancer treatment

      Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
      Innovation
      A 3D illustration blue ribcage on a red background

      An eye for innovation: helping surgeons see more during spinal operations

      With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
      Health & wellness
      A close-up of someone with green and yellow blood pressure cuffs on their legs

      5 things we now know about peripheral artery disease

      The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      Latest News
      A black female scientist in goggles viewing yellow liquid in a beaker

      Johnson & Johnson named a 2024 Fortune World’s Most Admired Company

      The company makes the list for the 22nd year in a row, thanks to its dedication to innovation, social responsibility and more.
      Innovation
      Brain scans may catch Alzheimer's disease before it starts

      Could we be on the cusp of catching Alzheimer’s before it starts?

      The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
      Health & wellness
      A man and a boy getting haircuts at a barber shop

      “As black men, we keep things close to the hip": 5 questions for a urologist about prostate cancer

      The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. For Black History Month, we spoke with a physician about building awareness and normalizing tough conversations.
      Latest news
      Illustration depicting diversity, including a black girl, a black baby and a black woman

      Driving diversity in medical illustration

      For Black History Month, learn how a new online database supported by Johnson & Johnson aims to promote racial health equity by increasing imagery of people of color.
      Health & wellness
       Blue latex gloved hand pointing at a brain MRI scan to pinpoint brain circuits associated with depression symptoms

      Is this the end of one-size-fits-all treatments for depression?

      Johnson & Johnson is working to bring personalized psychiatry to the 7 in 10 people with depression whose treatments aren’t getting the job done.
      Caring & giving
      how-johnson-johnson-is-helping-build-a-sense-of-belonging-by-investing-in-student-nurses-of-color-0923-new.jpg

      How Johnson & Johnson is helping build a sense of belonging by investing in student nurses of color

      A diverse nursing workforce is a better nursing workforce—one that improves quality of care and patient outcomes for all populations. That’s why Johnson & Johnson has put its support behind two pilot programs aimed at setting nurses up for success on campus and in healthcare settings.
      Innovation
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Personal stories
      A close-up of a doctor with their arms crossed across their chest

      Advancing diversity: 3 healthcare experts share their career stories

      The statistics are stark: People of color are vastly underrepresented in medical and scientific professions. But various programs—including ones sponsored by Johnson & Johnson—are working to help level the playing field.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.